VX15/2503
IRB00103534
Phase 1 mab active
Quick answer
VX15/2503 for Squamous Cell Carcinoma of the Head and Neck is a Phase 1 program (mab) at VACCINEX, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VACCINEX, INC.
- Indication
- Squamous Cell Carcinoma of the Head and Neck
- Phase
- Phase 1
- Modality
- mab
- Status
- active